Rockwell Medical
RMTI
34 hedge funds and large institutions have $9.06M invested in Rockwell Medical in 2024 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 5 closing their positions.
0.05% more ownership
Funds ownership: 1.81% → 1.86% (+0.05%)
0% more funds holding
Funds holding: 34 → 34 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
7% less capital invested
Capital invested by funds: $9.73M → $9.06M (-$670K)
11% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 9
28% less call options, than puts
Call options by funds: $62K | Put options by funds: $86K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$1.13M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$63K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$48.2K |
| 4 |
Squarepoint
New York
|
+$47.2K |
| 5 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$47.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$418K |
| 2 |
RB
Richmond Brothers
Jackson,
Michigan
|
-$131K |
| 3 |
Renaissance Technologies
New York
|
-$127K |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$112K |
| 5 |
Two Sigma Investments
New York
|
-$90.2K |
RMTI Hedge Fund Activity: Q1 2024 in Review
34 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Rockwell Medical (RMTI) for Q1 2024, worth a combined $9.06M — down 6.9% from $9.73M a quarter earlier.
Fund positioning in RMTI was balanced in Q1 2024: 5 funds opened new positions, 5 closed out, 8 added to existing stakes and 9 trimmed.
The largest buyer was Armistice Capital, adding an estimated $1.13M. The largest seller was Raymond James & Associates, exiting entirely with an estimated $418K sold.
- 34 institutional investors held Rockwell Medical (RMTI) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $9.06M of Rockwell Medical stock for Q1 2024, down 6.9% quarter-over-quarter.
- 5 funds opened new Rockwell Medical positions in Q1 2024 and 5 closed out, a net change of 0 holders.
- The largest Rockwell Medical buyer in Q1 2024 was Armistice Capital, an estimated $1.13M added.
- The largest Rockwell Medical seller in Q1 2024 was Raymond James & Associates, an estimated $418K sold.
Based on aggregated 13F filings for Q1 2024.